CoChat

Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials

Open access

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

This systematic review and network meta-analysis (NMA) sought to compare different antidepressant treatments for treatment-resistant depression (TRD) in order to facilitate evidence-based choices. A literature search of PubMed, Cochrane Library, and Embase from inception until April 13th, 2023 identified randomized, controlled trials (RCTs) of adults with depression who had not responded to at least two antidepressant trials; all RCTs had ≥10 participants per study arm, and participants with bipolar or psychotic depression were excluded. The Cochrane Risk of Bias Tool-2 was used to assess study quality. Response rate was the primary outcome measure. Odds ratios (ORs) using a random effects NMA are reported. From 8234 records, 69 RCTs were included in this analysis, encompassing 10,285 participants (5662 F/4623 M) and 25 separate treatments. Six of the 25 treatments demonstrated a higher response rate versus placebo or sham treatment: electroconvulsive therapy (ECT), minocycline, theta-burst stimulation (TBS), repetitive transcranial magnetic stimulation (rTMS), ketamine, and aripiprazole. ORs ranged from 1.9 (95%CI = [1.25; 2.91]) for aripiprazole to 12.86 (95%CI = [4.07; 40.63]) for ECT. Moderate heterogeneity of the model was observed (I 2 = 47.3% (95%CI [26.8–62%]). Of the included studies, 12.5% were rated as having high risk of bias, 28.13% as having low risk, and 59.38% as showing some concerns. Several effective treatments for TRD showed robust treatment effects across outcomes (ECT, TBS, rTMS, and ketamine), and others showed promising results for some, but not all, outcomes (minocycline, aripiprazole). These findings may help guide evidence-based treatment choices for TRD. Study Registration: PROSPERO (#CRD42023420584).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-024-02044-5

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study selection process. NMA=network meta-analysis.
Fig. 1 Study selection process. NMA=network meta-analysis.CC BY · PubMed Central
Fig. 2 Network graph for response rate. The width of the lines is proportional to the number of participants compared between two treatments. Lines indicate trials with direct comparisons. DBS=deep brain stimulation; ECT=electroconvulsive therapy; tDCS=transcranial direct current stimulation; TBS=theta burst stimulation; rTMS=repetitive transcranial magnetic therapy; XR=extended release.
Fig. 2 Network graph for response rate. The width of the lines is proportional to the number of participants compared between two treatments. Lines indicate trials with direct comparisons. DBS=deep brain stimulation; ECT=electroconvulsive therapy; tDCS=transcranial direct current stimulation; TBS=theta burst stimulation; rTMS=repetitive transcranial magnetic therapy; XR=extended release.CC BY · PubMed Central
Fig. 3 Forest plot for response rate to antidepressant treatments for treatment-resistant depression compared to placebo or sham. Significant results are displayed in red. Size of squares is proportional to number of participants included for each treatment. DBS=deep brain stimulation; tDCS=transcranial direct current stimulation; rTMS=repetitive transcranial magnetic stimulation; TBS=theta-burst stimulation; ECT=electroconvulsive therapy; OR=odds ratio; CI=confidence interval.
Fig. 3 Forest plot for response rate to antidepressant treatments for treatment-resistant depression compared to placebo or sham. Significant results are displayed in red. Size of squares is proportional to number of participants included for each treatment. DBS=deep brain stimulation; tDCS=transcranial direct current stimulation; rTMS=repetitive transcranial magnetic stimulation; TBS=theta-burst stimulation; ECT=electroconvulsive therapy; OR=odds ratio; CI=confidence interval.CC BY · PubMed Central
Fig. 4 Forest plot for response rate of antidepressant treatment groups compared to placebo. NMDAR = N-methyl-D-aspartate receptor.
Fig. 4 Forest plot for response rate of antidepressant treatment groups compared to placebo. NMDAR = N-methyl-D-aspartate receptor.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 70

Metadata

Authors
Saelens, J., Gramser, A., Watzal, V., Zarate, C. A., Lanzenberger, R., & Kraus, C.
Affiliations
  • Medical University of Vienna (AT)
  • National Institutes of Health (US)
Corresponding author
Kraus, Christoph
Venue
Neuropsychopharmacology
Published
2024-12-30
Volume
50
Issue
6
Pages
913-919
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W4405890096
Cited by
51
References
26
Citations by year
2026: 35 · 2025: 16
FWCI
3.19
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuropsychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (ZIAMH002857)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
treatment-resistant depression, antidepressant treatment, electroconvulsive therapy, minocycline, theta burst stimulation, repetitive transcranial magnetic stimulation, ketamine, aripiprazole, response rate, non-pharmacological depression treatment
MeSH terms
Network Meta-Analysis as Topic, Antidepressive Agents, Humans, Randomized Controlled Trials as Topic, Treatment Outcome, Depressive Disorder, Treatment-Resistant

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1038/s41386-024-02044-5
The paper
Saelens, J., Gramser, A., Watzal, V., Zarate, C. A., Lanzenberger, R., & Kraus, C. (2025). Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials. Neuropsychopharmacology. https://doi.org/10.1038/s41386-024-02044-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.